These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

722 related articles for article (PubMed ID: 27930620)

  • 1. Atypical hemolytic uremic syndrome (aHUS): essential aspects of an accurate diagnosis.
    Laurence J; Haller H; Mannucci PM; Nangaku M; Praga M; Rodriguez de Cordoba S
    Clin Adv Hematol Oncol; 2016 Nov; 14 Suppl 11(11):2-15. PubMed ID: 27930620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical hemolytic uremic syndrome (aHUS): making the diagnosis.
    Laurence J
    Clin Adv Hematol Oncol; 2012 Oct; 10(10 Suppl 17):1-12. PubMed ID: 23187605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The complex differential diagnosis between thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: Laboratory weapons and their impact on treatment choice and monitoring.
    Mannucci PM; Cugno M
    Thromb Res; 2015 Nov; 136(5):851-4. PubMed ID: 26386489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement activation in diseases presenting with thrombotic microangiopathy.
    Meri S
    Eur J Intern Med; 2013 Sep; 24(6):496-502. PubMed ID: 23743117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural history of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
    Wada H; Matsumoto T; Yamashita Y
    Semin Thromb Hemost; 2014 Nov; 40(8):866-73. PubMed ID: 25377323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The utility of ADAMTS13 in differentiating TTP from other acute thrombotic microangiopathies: results from the UK TTP Registry.
    Hassan S; Westwood JP; Ellis D; Laing C; Mc Guckin S; Benjamin S; Scully M
    Br J Haematol; 2015 Dec; 171(5):830-5. PubMed ID: 26359646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and management of complement mediated thrombotic microangiopathies.
    Cataland SR; Wu HM
    Blood Rev; 2014 Mar; 28(2):67-74. PubMed ID: 24534133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of ADAMTS-13 activity and complement mutational analysis in differentiating acute thrombotic microangiopathies.
    Phillips EH; Westwood JP; Brocklebank V; Wong EK; Tellez JO; Marchbank KJ; McGuckin S; Gale DP; Connolly J; Goodship TH; Kavanagh D; Scully MA
    J Thromb Haemost; 2016 Jan; 14(1):175-85. PubMed ID: 26559391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis and treatment of TMA based on Japanese clinical guides].
    Wada H; Hasegawa K; Watanabe M
    Rinsho Ketsueki; 2017; 58(7):849-856. PubMed ID: 28781284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand.
    Fox LC; Cohney SJ; Kausman JY; Shortt J; Hughes PD; Wood EM; Isbel NM; de Malmanche T; Durkan A; Hissaria P; Blombery P; Barbour TD
    Nephrology (Carlton); 2018 Jun; 23(6):507-517. PubMed ID: 29419916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HUS and TTP: traversing the disease and the age spectrum.
    Donadelli R; Sinha A; Bagga A; Noris M; Remuzzi G
    Semin Nephrol; 2023 Jul; 43(4):151436. PubMed ID: 37949684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombotic microangiopathies: thrombotic thrombocytopenic purpura / hemolytic uremic syndrome.
    Polito MG; Kirsztajn GM
    J Bras Nefrol; 2010; 32(3):303-15. PubMed ID: 21103695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathology Consultation on the Diagnosis and Treatment of Thrombotic Microangiopathies (TMAs).
    Williams LA; Marques MB;
    Am J Clin Pathol; 2016 Feb; 145(2):158-65. PubMed ID: 27124904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic approach to microangiopathic hemolytic disorders.
    Kottke-Marchant K
    Int J Lab Hematol; 2017 May; 39 Suppl 1():69-75. PubMed ID: 28447417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Atypical HUS caused by complement-related abnormalities].
    Yoshida Y; Matsumoto M
    Rinsho Ketsueki; 2015 Feb; 56(2):185-93. PubMed ID: 25765799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombotic Thrombocytopenic Purpura and Atypical Hemolytic Uremic Syndrome Microangiopathy in Pregnancy.
    Scully M
    Semin Thromb Hemost; 2016 Oct; 42(7):774-779. PubMed ID: 27648610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thrombotic microangiopathies in surgical intensive care medicine with special consideration of atypical hemolytic uremic syndrome].
    Albrecht S; Kamla CE; Schönermarck U; Wassilowsky D
    Anaesthesiologie; 2023 Jan; 72(1):3-12. PubMed ID: 36454255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: clinically differentiating the thrombotic microangiopathies.
    Cataland SR; Wu HM
    Eur J Intern Med; 2013 Sep; 24(6):486-91. PubMed ID: 23739653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does severe ADAMTS13 deficiency in thrombotic microangiopathy rule out complement-mediated atypical hemolytic uremic syndrome.
    Arumugam V; Bhowmick R; Agarwal I; Arumadi M
    Saudi J Kidney Dis Transpl; 2019; 30(3):701-705. PubMed ID: 31249236
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 37.